JS
Julie Sunderland
OtherActive16
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Julie Sunderland.
Investment Activity
Deals per year over the last 5 years
4
20154
20161
20172
20181
2019Portfolio Companies
Selected investments from their portfolio of 16 companies
E
Encodia
Biotech · Seed, 2019
V
Verve Therapeutics
Biotech · Series A, 2018
V
Verana Health
Healthcare · Series B, 2018
C
Cytrellis Biosystems
Biotech · Series B, 2017
Q
Qihan Biotech
Biotech · Series A, 2016
T
Thrive Earlier Detection
Healthcare · Series B, 2016
O
Omniome
Biotech · Series B, 2016
G
Grail
Biotech · Series B, 2016
B
BlackThorn Therapeutics
Biotech · Series A, 2015
E
EGenesis
Biotech · Series A, 2015
D
Denali Therapeutics
Biotech · Series A, 2015
C
Compass Therapeutics
Biotech · Series A, 2015
Frequently Asked Questions
Julie Sunderland invests across multiple stages. Sign up to view detailed stage data.